Gender of offspring and maternal ovarian cancer risk
Introduction
Ovarian cancer is responsible for more deaths than any other cancer of the female reproductive system, with less than 50% of women in the United States surviving 5 years after diagnosis [1]. It is estimated that 22,220 American women will be diagnosed with ovarian cancer in the year 2005, and approximately 16,210 of these women will die [1], due, in part, to the lack of effective prevention and early detection methods. Increased understanding of the etiology of ovarian cancer may inform preventative strategies.
It is well-documented that a single live birth compared to nulliparity substantially reduces the risk for ovarian cancer, and the risk declines for each additional full-term pregnancy [2]. Exactly how pregnancy reduces ovarian cancer risk is unknown. Several hypotheses posed to explain the association include: reduction in number of ovulations [3], lower circulating gonadotropins [4], reduced inflammation [5], and altered circulating steroid hormones [6].
Fetal sex differentially alters the maternal hormonal milieu during normal pregnancy [7], [8], [9], [10], [11], [12], [13]. In particular, circulating concentrations of estriol [14], alpha-fetoprotein, and human chorionic gonadotropin [7], [8], [9], [10], [13] are lower in mothers of male fetuses; whether these differences relate to ovarian cancer risk is unknown. Since fetal sex is associated with some circulating maternal hormones, it is possible that an altered hormonal milieu might modify the protective effect of childbearing on hormonally linked cancers such as ovarian cancer. Epidemiologic studies of offspring gender and ovarian cancer risk are lacking. Bearing male offspring was associated with a reduced risk of breast cancer, another hormonally-related cancer, in one study [15], although not consistently [16], [17], [18], [19]. These observations led us to investigate the association between offspring gender and maternal ovarian cancer risk in a large population-based case-control study of ovarian cancer.
Section snippets
Materials and methods
The SHARE (Study of Health and Reproduction) study design and methodology have been described in detail [5], [20]. Briefly, SHARE is a population-based, case-control study of contraceptive and reproductive risk factors for epithelial ovarian cancer. Cases were women age 20 to 69 with a diagnosis of incident epithelial ovarian cancer within the 6 months prior to interview. Eligible cases (n = 873) were identified from 39 hospitals around the Delaware Valley from May 1994 to July 1998. Fourteen
Results
Among the 511 cases, 82% of the tumors were categorized as invasive. The classification of the histologic types was as follows: serous, 48%; endometroid, 18%; mucinous, 14%; clear cell, 5%; other, 15%. This distribution of histologic types is consistent with that observed in other studies [23], [24], [25]. Table 1 shows the demographic and reproductive risk factor data for the 511 cases and 1136 controls with at least one singleton birth. Case-control differences were generally consistent with
Discussion
In this study, we investigated the association between gender of offspring and epithelial ovarian cancer. Overall, our data suggest that compared to having all girls, bearing both male and female offspring may be associated with a decrease in maternal ovarian cancer risk.
The length of the follicular phase and the hormone concentration at the time of conception are believed to influence the sex ratio [26], [27]. To our knowledge, only one previous study has evaluated the association between
Acknowledgments
This work was supported by contracts from: R01CA61095 (NCI), KO7-CA80668 (NCI), DAMD17-00-1-0569 (DOD).
References (28)
Incessant ovulation—A factor in ovarian neoplasia? (letter)
Lancet
(1971)- et al.
Maternal serum human chorionic gonadotropin concentrations and fetal sex prediction
Fertil. Steril.
(1980) - et al.
Cancer statistics, 2005
CA Cancer J. Clin.
(2005) - et al.
Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies: II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group
Am. J. Epidemiol.
(1992) - et al.
Determinants of ovarian cancer risk: II. Inferences regarding pathogenesis
J. Natl. Cancer Inst.
(1983) - et al.
Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer
Epidemiology
(2000) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone
J. Natl. Cancer Inst.
(1998)- et al.
Outcome of pregnancy in relation to maternal serum alpha-fetoprotein levels in the second trimester. An evaluation of a screening program and a longitudinal follow-up
Gynecol. Obstet. Invest.
(1988) - et al.
Fetal sex and maternal alpha-fetoprotein concentration at late normal singleton pregnancies
Acta Obstet. Gynecol. Scand.
(1994) - et al.
Correlation between fetal sex and human chorionic gonadotropin in peripheral maternal blood and amniotic fluid in second and third trimester normal pregnancies
Acta Obstet. Gynecol. Scand.
(1999)